Indication: This product is used to treat hypercholesterolemia.

Indication: This product is suitable for hypophosphatemia. Hypophosphatemia can occur in acute situations, such as blood transfusion, surgery under extracorporeal circulation, parenteral nutrition, and is also related to the depletion of carbonic acid in some chronic diseases, such as chronic alcoholism, long-term malnutrition, and chronic respiratory failure.

Indication: This product is suitable for hypophosphatemia. Hypophosphatemia can occur in acute situations, such as blood transfusion, surgery under extracorporeal circulation, parenteral nutrition, and is also related to the depletion of carbonic acid in some chronic diseases, such as chronic alcoholism, long-term malnutrition, and chronic respiratory failure.

Indication: This product is suitable for hypophosphatemia. Hypophosphatemia can occur in acute situations, such as blood transfusion, surgery under extracorporeal circulation, parenteral nutrition, and is also related to the depletion of carbonic acid in some chronic diseases, such as chronic alcoholism, long-term malnutrition, and chronic respiratory failure.

Indication: This product is suitable for hypophosphatemia. Hypophosphatemia can occur in acute situations, such as blood transfusion, surgery under extracorporeal circulation, parenteral nutrition, and is also related to the depletion of carbonic acid in some chronic diseases, such as chronic alcoholism, long-term malnutrition, and chronic respiratory failure.

Indication: It is used for patients with type 2 diabetes who are not satisfied with diet control alone, especially those who are obese and have hyperinsulinemia. This drug not only has the effect of lowering blood sugar, but also has the effect of reducing weight and hyperinsulinemia. It can be effective for patients with poor efficacy of certain sulfonylureas. For example, it is more effective when used in combination with sulfonylurea hypoglycemic drugs, intestinal glycosidase inhibitors or thiazolidinedione hypoglycemic drugs than when used alone. It can also be used for patients treated with insulin to reduce the amount of insulin.

Indication: 1. This product is used for infants aged 3 months to 2 years, and children aged 2 years to 5 years who have not been vaccinated with this vaccine (please refer to [Precautions] for high-risk groups). Recommended routine immunization program: basic immunization at 3, 4, and 5 months of age, and booster immunization at 12 to 15 months of age. 2. This product is used for active immunization of infants and young children to prevent invasive diseases caused by the 7 serotypes of pneumococci included in this vaccine (4, 6B, 9V, 14, 18C, 19F and 23F). Pneumococcus is a common cause of invasive infections (including sepsis, meningitis, bacteremic pneumonia and bacteremia), as well as upper respiratory tract infections such as pneumonia. Infants and young children under 2 years old are at the highest risk of invasive diseases. 3. The use of this vaccine should take into account the differences in the serotypes of pneumococcal diseases caused by different regions and the impact of invasive diseases on different age groups. This vaccine does not prevent infections caused by other types of pneumococci other than the serotypes included in the vaccine, nor does it prevent invasive infections caused by other microorganisms.